MDT · NYSE
Medtronic (MDT) Stock Price & Fundamentals
Medtronic (MDT) closed at $387.18 on Oct 9, 2026, up 0.80% from the previous close of $384.09.
Share price, past year
1Y −8.30%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $387.18 |
| Sep 30, 2026 | $389.89 |
| Aug 31, 2026 | $430.27 |
| Jul 31, 2026 | $415.54 |
| Jun 30, 2026 | $434.01 |
| May 29, 2026 | $453.42 |
| Apr 30, 2026 | $452.45 |
| Mar 31, 2026 | $448.68 |
| Feb 27, 2026 | $431.42 |
| Jan 30, 2026 | $435.09 |
| Dec 31, 2025 | $418.29 |
| Nov 28, 2025 | $398.36 |
| Oct 31, 2025 | $397.57 |
Key statistics
- Market cap
- $495.61B
- P/E (TTM)
- 95.4
- EPS (TTM)
- $4.06
- Revenue (TTM)
- $37.54B
- Net income (TTM)
- $5.23B
- Shares outstanding
- 1.3B
- Dividend yield
- 0.74%
- 52-week range
- $384.09 – $467.73
Medtronic's market cap is $495.61B, based on a share price of $387.18 and 1.3B shares outstanding as of Jul 31, 2026.
Financials
Medtronic reported revenue of $36.36B for fiscal 2026, up 8.43% from fiscal 2025.
Medtronic earned net income of $4.80B in fiscal 2026, a net margin of 13.2%.
Fiscal 2026 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Apr 24, 2026 | $36.36B | +8.4% | $4.80B | 13.2% | $3.73 | $5.43B |
| FY2025ended Apr 25, 2025 | $33.54B | +3.6% | $4.66B | 13.9% | $3.61 | $5.19B |
| FY2024ended Apr 26, 2024 | $32.36B | +3.6% | $3.68B | 11.4% | $2.76 | $5.20B |
| FY2023ended Apr 28, 2023 | $31.23B | −1.5% | $3.76B | 12.0% | $2.82 | $4.58B |
| FY2022ended Apr 29, 2022 | $31.69B | +5.2% | $5.04B | 15.9% | $3.73 | $5.98B |
| FY2021ended Apr 30, 2021 | $30.12B | +4.2% | $3.61B | 12.0% | $2.66 | $4.89B |
| FY2020ended Apr 24, 2020 | $28.91B | −5.4% | $4.79B | 16.6% | $3.54 | $6.02B |
| FY2019ended Apr 26, 2019 | $30.56B | +2.0% | $4.63B | 15.2% | $3.41 | $5.87B |
| FY2018ended Apr 27, 2018 | $29.95B | +0.8% | $3.10B | 10.4% | $2.27 | $3.62B |
| FY2017ended Apr 28, 2017 | $29.71B | — | $4.03B | 13.6% | $2.89 | $5.63B |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2027ended Jul 31, 2026 | $9.76B | $1.47B | $1.14 |
| Q4 FY2026ended Apr 24, 2026 | $9.81B | $1.24B | $0.96 |
| Q3 FY2026ended Jan 23, 2026 | $9.02B | $1.14B | $0.89 |
| Q2 FY2026ended Oct 24, 2025 | $8.96B | $1.37B | $1.07 |
| Q1 FY2026ended Jul 25, 2025 | $8.58B | $1.04B | $0.81 |
| Q4 FY2025ended Apr 25, 2025 | $8.93B | $1.06B | $0.81 |
| Q3 FY2025ended Jan 24, 2025 | $8.29B | $1.29B | $1.01 |
| Q2 FY2025ended Oct 25, 2024 | $8.40B | $1.27B | $0.99 |
Company profile
- Name
- Medtronic plc
- Ticker
- MDT
- Exchange
- NYSE
- Industry (SEC SIC)
- Electromedical & Electrotherapeutic Apparatus
- Headquarters
- Building Two Parkmore Business Park West, Galway, H91 4K49
- Fiscal year ends
- April
- SEC CIK
- 0001613103
Recent SEC filings
- Sep 17, 2026
- Sep 3, 2026
- Sep 1, 2026
- Jun 18, 2026
- Jun 3, 2026
- May 18, 2026
- Apr 27, 2026
- Mar 24, 2026
Frequently asked questions
What is Medtronic's stock price?
Medtronic (MDT) closed at $387.18 on Oct 9, 2026, up 0.80% from the previous close of $384.09.
What is Medtronic's market cap?
Medtronic's market cap is $495.61B, based on a share price of $387.18 and 1.3B shares outstanding as of Jul 31, 2026.
How much revenue does Medtronic make?
Medtronic reported revenue of $36.36B for fiscal 2026, up 8.43% from fiscal 2025.
What is MDT's P/E ratio?
Medtronic's price-to-earnings ratio is 95.4, based on trailing twelve-month diluted EPS of $4.06.
Does Medtronic pay a dividend?
Yes. Medtronic declared $2.85 per share in dividends over the last four quarters, a yield of 0.74%.
Sources and methodology
Fundamentals come from Medtronic plc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures